$58.52 0.00 (%) AbbVie Inc - NYSE

Sep. 29, 2014 | 04:00 PM

Partner Headlines

  1. Pharma Stocks: Surprising Shift In U.S. Drug Market

    YCharts | Sep. 29, 2014 | 08:15AM EST
  2. There's More to Gilead Sciences than a Successful Drug

    GuruFocus | Sep. 26, 2014 | 19:07PM EST
  3. AbbVie Inc Spikes On Reported End-Run Around Inversion Rules

    Benzinga | Sep. 26, 2014 | 11:21AM EST
  4. A Few Reasons Why AbbVie's Momentum Will Continue

    GuruFocus | Sep. 25, 2014 | 17:53PM EST
  5. Gilead's New HIV Drug Key To Long-Term Strategy

    IBD | Sep. 24, 2014 | 17:29PM EST
  6. Celgene's

    IBD | Sep. 23, 2014 | 18:45PM EST
  7. Tax Inversion Rules Hit Firms

    IBD | Sep. 23, 2014 | 18:36PM EST
  8. Stocks Fall To Session Lows; Vipshop Bucks The Trend

    IBD | Sep. 23, 2014 | 15:00PM EST
  9. Stocks Lower In Afternoon Trading; CarMax Plunges

    IBD | Sep. 23, 2014 | 13:23PM EST
  10. Inversion Crackdown Leaves Several Deals In Limbo

    Benzinga | Sep. 23, 2014 | 12:41PM EST
  11. Shares Feel The Squeeze Of Treasury's Inversion Rules

    IBD | Sep. 23, 2014 | 12:25PM EST
  12. Bank Of America Believes Anti-Inversion Rules Are Not A Deal-Breaker For AbbVie Inc

    Benzinga | Sep. 23, 2014 | 11:16AM EST
  13. Morning Market Losers

    Benzinga | Sep. 23, 2014 | 09:47AM EST
  14. Benzinga's Top #PreMarket Losers

    Benzinga | Sep. 23, 2014 | 08:20AM EST
  15. #PreMarket Primer: Tuesday, September 23: First Airstrikes In Syria Begin

    Benzinga | Sep. 23, 2014 | 07:28AM EST
  16. 3 Partnerships Pushing The Pharmaceutical Sector Forward

    Benzinga | Sep. 22, 2014 | 12:59PM EST
  17. Google Makes a Breakthrough in Life Science

    GuruFocus | Sep. 18, 2014 | 15:06PM EST
  18. Gilead Stock Is Falling On These Drug Setbacks

    IBD | Sep. 17, 2014 | 12:52PM EST
  19. Lipocine Inc Halted: Feds Eye Safety, Efficacy Of Testosterone

    Benzinga | Sep. 17, 2014 | 11:45AM EST
  20. Gilead Up As Analyst Lifts Sovaldi Q3 Estimate

    IBD | Sep. 16, 2014 | 13:57PM EST
  21. Valeant, Allergan Settle Suit, Allow Shareholder Vote

    IBD | Sep. 16, 2014 | 11:36AM EST
  22. Gilead, Jazz, Salix Among Top 6 IBD 50 Drugmakers

    IBD | Sep. 13, 2014 | 08:02AM EST
  23. Corporate Tax Cuts Would Help Treasury And Investors

    IBD | Sep. 11, 2014 | 18:04PM EST
  24. US Stock Futures Drop Ahead Of Jobless Claims Report

    Benzinga | Sep. 11, 2014 | 07:18AM EST
  25. AbbVie Announces Pivotal Phase 3 Data Evaluating Efficacy Of HUMIRA In Patients With Hidradenitis Suppurativa, A Chronic Inflammatory Skin Disease

    Benzinga | Sep. 11, 2014 | 04:33AM EST
  26. Google Inc Expands Biotech Investment With Life Labs Buy

    Benzinga | Sep. 10, 2014 | 15:41PM EST
  27. Pharmacyclics Price Target Cut On Higher Spending

    IBD | Sep. 8, 2014 | 13:02PM EST
  28. Why Gilead Is Falling On Drugs For Developing Nations

    IBD | Sep. 5, 2014 | 15:15PM EST
  29. Infinity, AbbVie team on drug

    IBD | Sep. 3, 2014 | 18:36PM EST
  30. S&P 500 Struggles To Hold 2,000 As Commodities Rebound

    Benzinga | Sep. 3, 2014 | 17:01PM EST
  31. Midday Gainers From Wednesday, September 3

    Benzinga | Sep. 3, 2014 | 14:41PM EST
  32. Infinity Pharma Joins AbbVie On Blood Cancer Drug

    IBD | Sep. 3, 2014 | 13:20PM EST
  33. NASDAQ Tumbles 0.5%; Infinity Pharmaceuticals Jumps On Deal With AbbVie

    Benzinga | Sep. 3, 2014 | 13:01PM EST
  34. Markets Gain; Toll Brothers Profit Beats Estimates

    Benzinga | Sep. 3, 2014 | 11:22AM EST
  35. Benzinga's Volume Movers

    Benzinga | Sep. 3, 2014 | 10:27AM EST
  36. Morning Market Movers

    Benzinga | Sep. 3, 2014 | 09:43AM EST
  37. Stock Futures Up And Climbing; Baidu Heads China Stock Rally

    IBD | Sep. 3, 2014 | 09:08AM EST
  38. Benzinga's Top #PreMarket Gainers

    Benzinga | Sep. 3, 2014 | 08:04AM EST
  39. I Am Sure This Pharma-Company Suits Your Portfolio

    GuruFocus | Aug. 28, 2014 | 13:52PM EST
  40. Benzinga's M&A Chatter for Wednesday August 27, 2014

    Benzinga | Aug. 27, 2014 | 20:45PM EST
  41. After Reaching All-Time Highs, How Can Gilead Sciences Continue growing?

    GuruFocus | Aug. 27, 2014 | 15:06PM EST
  42. Bristol-Myers Hepatitis C Therapy Approved in EU

    IBD | Aug. 27, 2014 | 12:03PM EST
  43. IRS, Eh? Tim Hortons Deal Could Lower Burger King's Tax Bill

    FoxBusiness | Aug. 25, 2014 | 14:10PM EST
  44. Why Burger King Isn't Like Walgreen In Tax Inversions

    IBD | Aug. 25, 2014 | 13:23PM EST
  45. Biotech Leader Gilead Sciences Scores Sovaldi Win

    IBD | Aug. 15, 2014 | 18:10PM EST
  46. Gilead Wins Sovaldi Dispute With Roche, U.K. Nod

    IBD | Aug. 15, 2014 | 12:23PM EST
  47. 5 Companies That Have Moved Overseas For Lower Taxes

    Benzinga | Aug. 12, 2014 | 10:06AM EST
  48. GW Pharma, Insys Face Off In Cannabis Drug Space

    IBD | Aug. 8, 2014 | 16:45PM EST
  49. Markets Little Changed As Ukraine Uncertainty And Fears Persist

    Benzinga | Aug. 6, 2014 | 16:58PM EST
  50. Walgreen Leads Sell-Off In 'Tax Inversion' Stocks

    IBD | Aug. 6, 2014 | 10:15AM EST
Trading Center